ru-28362 has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 1 studies
| Studies (ru-28362) | Trials (ru-28362) | Recent Studies (post-2010) (ru-28362) | Studies (n-methyl-3,4-methylenedioxyamphetamine) | Trials (n-methyl-3,4-methylenedioxyamphetamine) | Recent Studies (post-2010) (n-methyl-3,4-methylenedioxyamphetamine) |
|---|---|---|---|---|---|
| 175 | 0 | 3 | 4,276 | 211 | 1,392 |
| Protein | Taxonomy | ru-28362 (IC50) | n-methyl-3,4-methylenedioxyamphetamine (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.9351 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.1761 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 1.06 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.7609 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lowy, MT; Meltzer, HY; Nash, JF | 1 |
1 other study(ies) available for ru-28362 and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Androstanols; Animals; Corpus Striatum; Corticosterone; Hydroxyindoleacetic Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid; Serotonin | 1989 |